Evidence map›Paper›PMID 27785070›Full record

ArticleOncoTargets and therapy2016

Differential expression of two activating transcription factor 5 isoforms in papillary thyroid carcinoma.

Luisa Vicari, Cristina La Rosa, Stefano Forte, Giovanna Calabrese, Cristina Colarossi, Eleonora Aiello, Salvatore Salluzzo, Lorenzo Memeo

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Luisa VicariIOM Ricerca srl, Viagrande CT, Italy.
Cristina La RosaDepartment of Experimental Oncology, Istituto Oncologico del Mediterraneo, Viagrande CT, Italy; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Roma, Italy.
Stefano ForteIOM Ricerca srl, Viagrande CT, Italy.
Giovanna CalabreseIOM Ricerca srl, Viagrande CT, Italy.
Cristina ColarossiDepartment of Experimental Oncology, Istituto Oncologico del Mediterraneo, Viagrande CT, Italy.
Eleonora AielloDepartment of Experimental Oncology, Istituto Oncologico del Mediterraneo, Viagrande CT, Italy.
Salvatore SalluzzoDepartment of Experimental Oncology, Istituto Oncologico del Mediterraneo, Viagrande CT, Italy.
Lorenzo MemeoIOM Ricerca srl, Viagrande CT, Italy; Department of Experimental Oncology, Istituto Oncologico del Mediterraneo, Viagrande CT, Italy.
Istituto Oncologico Veneto · ITIstituto Superiore di Sanità · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundActivating transcription factor 5 (

methodsQuantitative real-time reverse transcription polymerase chain reaction and immuno-histochemical staining were used to study

resultsWe report here that

conclusionThese findings could provide potential applications in PTC cancer treatment.

Indexed as

ATF5IHCpapillary thyroid carcinomaqRT-PCRtherapeutic target

Identifiers

PMID27785070
PMCPMC5067000
OpenAlexW2530301711

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.